1. Home
  2. HOTH vs JVA Comparison

HOTH vs JVA Comparison

Compare HOTH & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • JVA
  • Stock Information
  • Founded
  • HOTH 2017
  • JVA 1971
  • Country
  • HOTH United States
  • JVA United States
  • Employees
  • HOTH N/A
  • JVA N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • HOTH Health Care
  • JVA Consumer Staples
  • Exchange
  • HOTH Nasdaq
  • JVA Nasdaq
  • Market Cap
  • HOTH 20.9M
  • JVA 24.0M
  • IPO Year
  • HOTH 2019
  • JVA 2005
  • Fundamental
  • Price
  • HOTH $1.54
  • JVA $4.46
  • Analyst Decision
  • HOTH Strong Buy
  • JVA
  • Analyst Count
  • HOTH 3
  • JVA 0
  • Target Price
  • HOTH $4.00
  • JVA N/A
  • AVG Volume (30 Days)
  • HOTH 1.1M
  • JVA 80.1K
  • Earning Date
  • HOTH 11-11-2025
  • JVA 09-12-2025
  • Dividend Yield
  • HOTH N/A
  • JVA N/A
  • EPS Growth
  • HOTH N/A
  • JVA 64.91
  • EPS
  • HOTH N/A
  • JVA 0.32
  • Revenue
  • HOTH N/A
  • JVA $89,748,681.00
  • Revenue This Year
  • HOTH N/A
  • JVA N/A
  • Revenue Next Year
  • HOTH N/A
  • JVA N/A
  • P/E Ratio
  • HOTH N/A
  • JVA $13.58
  • Revenue Growth
  • HOTH N/A
  • JVA 17.92
  • 52 Week Low
  • HOTH $0.65
  • JVA $2.75
  • 52 Week High
  • HOTH $3.80
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 46.54
  • JVA 46.94
  • Support Level
  • HOTH $1.46
  • JVA $4.22
  • Resistance Level
  • HOTH $1.72
  • JVA $4.63
  • Average True Range (ATR)
  • HOTH 0.13
  • JVA 0.21
  • MACD
  • HOTH -0.03
  • JVA -0.05
  • Stochastic Oscillator
  • HOTH 20.00
  • JVA 28.36

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: